Organisation paid for research Program year 2025 Source: CMS Open Payments

Future Options Research LLC

Neither a doctor nor a teaching hospital

Research payments

$295,766

12 payments

Through program year 2025, Future Options Research LLC is reported as receiving $295,766 in research payments, across 12 payments.

By program year

2 rows
Year Kind Amount Payments
2025 Research $89,993 10
2024 Research $205,773 2

Breakdown

Who paid Research payments · program years 2024–2025
  1. Boehringer Ingelheim Pharmaceuticals, Inc. $295,766 12 payments
Studies the money was for Research payments · program years 2024–2025
  1. Connex-3 $206,796 3 payments
  2. An open label, single arm, extension trial to examine long-term safety of BI 425809 once daily in patients with schizophrenia who have completed previous BI 425809 Phase III trials.(CONNEX-X) $44,169 7 payments
  3. Phase II dose finding trial in monotherapy for MDD $26,300 1 payment
  4. Connex-X $18,500 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record